Insider Trading & SAST disclosures for Dr. Datsons Labs Ltd.

There were no Insider Trade disclosures made for Dr. Datsons Labs Ltd.

The latest disclosures under SEBI SAST(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 transaction was made by Leman Diversified Fund in Dr. Datsons Labs Ltd. where Acquisition of 6,773,274 shares done was reported to the exchange on Feb. 2, 2015.

Insider trades are disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015 ([Regulation 7 (2) with 6(2)] made by corporate insiders: promoters, officers, directors, employees and large shareholders who are buying and selling stock in their own companies.

Client Name Client Category Action* Reported To/By Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Period Regulation (Insider/SAST) Security Type Mode
Leman Diversified Fund Other Acquisition 02 Feb 2015 6,773,274 6,773,274 (6.18%) 6.18% - 23 Jan 2015
23 Jan 2015
SAST (29(1)) - Market
Dr Kannan Vishwanath Promoter Disposal 02 Jan 2015 2,272,641 - 2.16% - 03 Mar 2014
30 Dec 2014
SAST (29(2)) - Invocation Of Pledged
Finaventure Capital Limited Promoter - 24 Dec 2024 600,000 0 - - 09 Dec 2014
09 Dec 2014
SAST (Reg31) - Invocation
Kannan Vishwanath Promoter - 24 Dec 2024 140,000 0 - - 09 Dec 2014
09 Dec 2014
SAST (Reg31) - Invocation
Auctor Investments Ltd Other Acquisition 02 Dec 2014 8,647,929 - 8.22% - 25 Nov 2014
25 Nov 2014
SAST (29(1)) - Conv. of FCCBs
Heshika Growth Fund Other Acquisition 02 Dec 2014 8,647,929 - 8.22% - 25 Nov 2014
25 Nov 2014
SAST (29(1)) - Conv. of FCCBs
Kannan Vishwanath Promoter - 24 Dec 2024 200,000 1,197,500 - - 13 Sep 2014
13 Sep 2014
SAST (Reg31) - Invocation
Kannan Vishwanath Promoter - 24 Dec 2024 150,000 1,397,500 - - 09 Jun 2014
09 Jun 2014
SAST (Reg31) - Invocation
Kannan Vishwanath Promoter Pledge 24 Dec 2024 400,000 1,547,500 - - 02 Jun 2014
02 Jun 2014
SAST (Reg31) - Invocation
Finaventure Capital Limited Promoter - 24 Dec 2024 207,498 900,000 - - 29 Mar 2014
29 Mar 2014
SAST (Reg31) - Invocation
Kuvera Fund Ltd Other Acquisition 27 Mar 2014 2,961,354 2,961,354 (9.36%) 9.36% - 18 Mar 2014
18 Mar 2014
SAST (29(1)) - Conv. of FCCBs
Finaventure Capital Limited Promoter - 24 Dec 2024 10,700 1,107,608 - - 31 Jan 2014
31 Jan 2014
SAST (Reg31) - Invocation
Evans Fraser & Co India Ltd Other Acquisition 29 Jan 2014 64,429 676,501 (4.87%) 0.46% - 27 Jan 2014
27 Jan 2014
SAST (29(2)) - Market
Nippon Investment & Finance Co. Pvt Ltd Other Acquisition 29 Jan 2014 250,000 688,526 (4.96%) 1.80% - 27 Jan 2014
27 Jan 2014
SAST (29(2)) - Market
Shree Dhoot Trading & Agencies Ltd Other Acquisition 29 Jan 2014 390,000 693,688 (5%) 2.81% - 27 Jan 2014
27 Jan 2014
SAST (29(2)) - Market
Shree Dhoot Trading & Agencies Ltd Other Acquisition 28 Jan 2014 303,688 303,688 (2.19%) 2.19% - 24 Jan 2014
24 Jan 2014
SAST (29(2)) - Market
Evans Fraser & Co India Ltd Other Acquisition 28 Jan 2014 352,426 612,072 (4.41%) 2.54% - 24 Jan 2014
24 Jan 2014
SAST (29(2)) - Market
Bakulesh T Shah Other Disposal 27 Jan 2014 1,310,000 - 9.43% - 24 Jan 2014
27 Jan 2014
SAST (29(2)) - Market
Finaventure Capital Limited Promoter - 24 Dec 2024 40,000 1,118,308 - - 22 Jan 2014
22 Jan 2014
SAST (Reg31) - Invocation
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal. 
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal. 
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.
View All The Insider Trades & SAST disclosures